Summary
Sets out Medicines & Healthcare products Regulatory Agency's approach to medicines/devices regulation in the age of AI, including evidence expectations, adaptivity, international recognition, and collaboration with the International Medical Device Regulators Forum and other regulators.
Healthcare Implications
Informs sponsors and National Health Service partners about the regulator’s priorities, including transparency and post‑market monitoring for AI‑enabled products. Useful for aligning development plans and regulatory strategies.